Latest filing published 07 Oct 2025 for Voyager Therapeutics, Inc., €31k.
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Filings by Nathan D. Jorgensen span 2 companies, the busiest being Vor Biopharma Inc. and Voyager Therapeutics, Inc. The record holds 18 filings, for trades running from 9 February 2021 to 24 February 2026.
On the market, this insider has only sold: 2 sales, €46k in total. The rest of the record consists of 15 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 26 February 2026 with an open-market sale (€15k) in Voyager Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations